Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Scholar Rock Holding Corporation (SRRK) vs Travere Therapeutics, Inc. (TVTX)

Scholar Rock Holding Corporation and Travere Therapeutics, Inc. are both Biotechnology companies. Scholar Rock Holding Corporation and Travere Therapeutics, Inc. are of similar size ($6.0B and $5.7B). Scholar Rock Holding Corporation grew revenue faster over the last twelve months: 213.7% against 77.1%. Scholar Rock Holding Corporation has the higher net margin (0.00% vs −7.35%) and the higher return on invested capital (0.00% vs −18.3%). Across the 17 metrics below, Travere Therapeutics, Inc. leads on 9 and Scholar Rock Holding Corporation on 8.

Valuation

Metric SRRK TVTX Biotechnology median
P/E n/m n/m 7.88
P/S 134.64 9.40 11.47
P/B 25.09 226.59 2.52
Price to free cash flow n/m 383.94 21.16
EV/EBITDA n/m 281.89 0.74
EV/Sales 128.39 9.59 10.73
Earnings yield (7.08%) (0.76%) (28.84%)
Free cash flow yield (4.66%) 0.26% (23.03%)

Profitability

Metric SRRK TVTX Biotechnology median
Gross margin 0.00% 98.60% 65.16%
Operating margin 0.00% (6.84%) 0.00%
Net margin 0.00% (7.35%) 0.00%
Free cash flow margin 0.00% 2.56% 0.00%
Return on equity (167.77%) (151.79%) (57.72%)
Return on assets (94.63%) (6.42%) (49.22%)
Return on invested capital 0.00% (18.31%) 0.00%

Growth

Metric SRRK TVTX Biotechnology median
Revenue growth (TTM) 213.65% 77.12% 5.64%
EPS growth (last fiscal year) (33.20%) 92.89% —
Revenue growth, 5-year CAGR — 19.87% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SRRK TVTX Biotechnology median
Debt to equity 0.77 24.58 0.00
Current ratio 7.02 4.05 4.73
Net debt to EBITDA 0.69 2.27 0.96

Dividend

Metric SRRK TVTX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric SRRK TVTX Biotechnology median
Market cap 5.96b 5.66b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack